DK2291380T3 - Nalmefen-prodrugs - Google Patents

Nalmefen-prodrugs

Info

Publication number
DK2291380T3
DK2291380T3 DK09733923.8T DK09733923T DK2291380T3 DK 2291380 T3 DK2291380 T3 DK 2291380T3 DK 09733923 T DK09733923 T DK 09733923T DK 2291380 T3 DK2291380 T3 DK 2291380T3
Authority
DK
Denmark
Prior art keywords
compounds
nalmefene
disorders
alcohol
prodrugs
Prior art date
Application number
DK09733923.8T
Other languages
English (en)
Inventor
Michel Joseph Maurice Andre Guillaume
Tim Gaekens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK2291380T3 publication Critical patent/DK2291380T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09733923.8T 2008-04-24 2009-04-23 Nalmefen-prodrugs DK2291380T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08155094 2008-04-24
PCT/EP2009/054882 WO2009130272A1 (en) 2008-04-24 2009-04-23 Nalmefene prodrugs

Publications (1)

Publication Number Publication Date
DK2291380T3 true DK2291380T3 (da) 2011-12-05

Family

ID=39816976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09733923.8T DK2291380T3 (da) 2008-04-24 2009-04-23 Nalmefen-prodrugs

Country Status (19)

Country Link
US (1) US8440686B2 (da)
EP (1) EP2291380B1 (da)
JP (1) JP6009764B2 (da)
KR (1) KR101598137B1 (da)
CN (1) CN102066381A (da)
AT (1) ATE523512T1 (da)
AU (1) AU2009239929B2 (da)
CA (1) CA2722246C (da)
CY (1) CY1112295T1 (da)
DK (1) DK2291380T3 (da)
ES (1) ES2373364T3 (da)
HR (1) HRP20110824T1 (da)
ME (1) ME01319B (da)
PL (1) PL2291380T3 (da)
PT (1) PT2291380E (da)
RS (1) RS52041B (da)
RU (1) RU2495042C2 (da)
SI (1) SI2291380T1 (da)
WO (1) WO2009130272A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018359336B2 (en) 2017-11-03 2024-06-20 Nirsum Laboratories, Inc. Opioid receptor antagonist prodrugs
TW202015684A (zh) * 2018-06-21 2020-05-01 景凱生物科技股份有限公司 那曲酮、納美芬及其衍生物之前藥
WO2020223894A1 (en) 2019-05-07 2020-11-12 Nirsum Laboratories, Inc. Opioid receptor antagonist prodrugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
JPH06271578A (ja) * 1993-03-15 1994-09-27 Natl Sci Council 鎮痛剤ナルブフィン前薬の誘導体
DE69427551T2 (de) 1993-03-15 2002-05-16 Nat Science Council Taipeh T A Nalbuphinester und diese enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
HUP0401022A3 (en) * 2001-08-14 2006-11-28 Biotie Therapies Corp Method for the preparation of pharmaceutical compositions containing opioid antagonist for treating alcoholism or alcohol abuse
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
US7759358B2 (en) * 2003-07-23 2010-07-20 Crooks Peter A Oral bioavailable prodrugs
WO2008101187A2 (en) * 2007-02-16 2008-08-21 Pharmacofore, Inc. Pro-drugs of peripheral phenolic opioid antagonists
ES2377599T3 (es) * 2008-04-24 2012-03-29 Janssen Pharmaceutica N.V. Profármacos di-éster de nalmefeno

Also Published As

Publication number Publication date
US20110034502A1 (en) 2011-02-10
HRP20110824T1 (hr) 2012-01-31
PT2291380E (pt) 2011-12-22
AU2009239929A1 (en) 2009-10-29
ES2373364T3 (es) 2012-02-02
ATE523512T1 (de) 2011-09-15
JP2011518805A (ja) 2011-06-30
CN102066381A (zh) 2011-05-18
WO2009130272A1 (en) 2009-10-29
SI2291380T1 (sl) 2012-01-31
EP2291380B1 (en) 2011-09-07
CA2722246C (en) 2016-06-21
US8440686B2 (en) 2013-05-14
RU2010147833A (ru) 2012-05-27
PL2291380T3 (pl) 2012-02-29
KR20110004877A (ko) 2011-01-14
AU2009239929B2 (en) 2014-02-13
CY1112295T1 (el) 2015-12-09
ME01319B (me) 2013-12-20
EP2291380A1 (en) 2011-03-09
CA2722246A1 (en) 2009-10-29
KR101598137B1 (ko) 2016-02-29
JP6009764B2 (ja) 2016-10-19
RU2495042C2 (ru) 2013-10-10
RS52041B (en) 2012-04-30

Similar Documents

Publication Publication Date Title
ATE535528T1 (de) Nalmefendiesterprodrugs
CA2871471C (en) Dna-pk inhibitors
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
MX2013001970A (es) Compuestos de pirrolopirimidina y usos de los mismos.
MX353806B (es) Quinolinas como moduladores de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr).
UA107783C2 (en) Isoindoline compounds for use in treating cancer
WO2014097151A3 (en) Autotaxin inhibitors
MX2013009873A (es) Inhibidores triciclicos de cinasas.
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
WO2010008847A3 (en) Pi3k/m tor inhibitors
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
UA110612C2 (uk) Похідні 1-аміно-2-циклопропілетилборонової кислоти
WO2011080568A8 (en) Novel pyrimidine compounds as mtor and pi3k inhibitors
WO2010147898A3 (en) Small molecule inhibitors of spleen tyrosine kinase (syk)
MY166653A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
MX349004B (es) Nuevos compuestos.
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
UA107183C2 (uk) Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
MX2009005938A (es) 6-oxo-1,6-dihidro-pirimidin-2-ilos en el tratamiento de enfermedades proliferativas.
WO2012162513A3 (en) Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase i inhibitors
CY1112295T1 (el) Προφαρμακα ναλμεφενης
WO2010027458A3 (en) Pdk inhibitor compounds and methods of use thereof
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
WO2011103028A3 (en) Compositions and methods for inhibiting mmset